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Abstract
Purpose of Review—Understanding of the aetiology of tubal ectopic pregnancy (tEP) remains
incomplete. We aim to summarize the latest advances in laboratory models of tEP that we believe
will, ultimately, contribute to improving the diagnosis and management of the condition.
Recent Findings—Progress in proteome pre-fractionation and multidimensional protein
identification technology has proved particularly effective in identifying novel biomarkers of tEP.
These, and related global proteomic and genomic approaches, have as yet to be fully exploited in
this context but do have substantial potential to inform future hypothesis driven studies. The
majority of data generated since 2009 to explain the aetiology of tEP continues to derive from
descriptive human ex-vivo studies. In-vitro models of Fallopian tube ciliary and smooth muscle
function have improved to a limited degree, on the back of continuing advances in imaging and
data acquisition. We believe that the recent development of a primary human Fallopian tube
epithelium culture system represents the most significant recent advance in laboratory models for
studying ectopic pregnancy. There remain no good animal models of tEP.
Summary—The establishment of a viable animal model of tEP remains the key obstacle to a
complete understanding the aetiology of the condition.
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Introduction
The diagnosis and clinical management of ectopic pregnancy remains a significant challenge
worldwide. Ectopic pregnancy is the leading cause of maternal death in the first trimester of
pregnancy in the developed world [1,2], while an estimated 10% of cases admitted to
hospitals in developing countries ultimately die from the condition [3].
An ectopic pregnancy is defined as any pregnancy implanted outside the uterus but the vast
majority (>98%) occur in the Fallopian tube [2,4] and the aetiology of tubal implantation is
still far from resolved. The bulk of the literature to date supports the hypothesis that it occurs
due to a combination of impaired embryo-tubal transport and alterations in the Fallopian
tube environment that allow implantation to occur [5]. However, no viable animal model of
tubal ectopic pregnancy (tEP) currently exists and the greater part of our knowledge derives
from descriptive studies of clinical cases [5,6]. If we are to understand its aetiology and,
ultimately, improve its diagnosis by identifying candidate biomarkers and advance clinical
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management by developing novel medical treatments, there is an absolute requirement for
good laboratory models of ectopic pregnancy.
Here we review the existing literature on the current laboratory models and their potential
for generating key functional data in the future.
Lessons from descriptive studies
Fallopian tube tissue is readily obtainable, with informed consent, from women undergoing
surgery for tEP. However, there is clearly no ethical prerogative for obtaining control
Fallopian tube tissue from women with healthy intrauterine pregnancies, and this in-itself
makes descriptive studies of gene and/or protein expression in the Fallopian tube of women
with ectopic pregnancy challenging. One option is to compare Fallopian tube tissue from
women with ectopic pregnancy with Fallopian tube tissue collected during the mid-luteal
phase of the menstrual cycle from non-pregnant women undergoing hysterectomy for benign
gynaecological conditions [7,8]. Another option is to compare the tissue to that obtained
from women in a pseudo-pregnant state, induced by treatment with human chorionic
gonadotropin in the days before hysterectomy [9]. Both have merit, but are ultimately open
to the possibility that any events observed in the ectopic group may also occur in the
Fallopian tube during a healthy intrauterine pregnancy and, therefore, be largely irrelevant.
Furthermore, as the data are associative, it is also impossible to ascribe any observed
changes to a cause or effect of ectopic pregnancy without following the observation up with
appropriate functional studies. Although the latter point may not be relevant to studies aimed
purely at identifying diagnostic markers of ectopic pregnancy, it is critical to placing any
observation in the context of understanding the aetiology of ectopic pregnancy or identifying
risk factors for the condition. Recent studies by our group into the role of prokineticins
exemplify this approach, by following up observations that smoking and past Chlamydia
trachomatis infection were associated with increased expression of prokineticin receptors −1
(PROKR1) and −2 (PROKR2), respectively, with functional studies that confirmed that the
smoking metabolite, cotinine, and C. trachomatis upregulate expression of PROKR1 and
PROKR2 in vitro [10,11].
Endometrium can also be obtained with informed consent from women undergoing surgery
for a tEP. When an embryo implants in the Fallopian tube, maternal cells at the implantation
site usually only display very limited, if any, decidual differentiation, but intrauterine
endometrial decidualisation is maintained [12]. Similarities in the cellular composition of
decidualised endometrium in ectopic and intrauterine pregnancies have been described
[13,14]. However, studies from our group have demonstrated that there are differences at a
morphological level, and in the expression of markers of decidualisation (prolactin and
IGFBP-1), natural antimicrobial peptides, inhibins/activins and cysteine-rich secretory
protein 3 in the decidualised endometrium of ectopic compared to intrauterine pregnancies
of similar gestations [15,16,17]. We have proposed these differences as a means of
identifying candidate serum biomarkers of ectopic implantation [18].
The availability, ethical considerations permitting, of normal trophoblast/embryo from
pregnant women undergoing surgical termination of viable pregnancy and surgical
management of miscarriage allows direct comparisons to be made between gestation-
matched intrauterine and tubal ectopic pregnancies. This approach lends itself to both
aetiology [19,20] and diagnostic biomarker [21] focused studies, but is complicated by the
technical difficulties involved in obtaining pure trophoblast samples free of maternal tissue
contamination [21].
Biological fluids, such as blood and urine, are much more readily accessible for laboratory
studies and are the continuing focus of attempts to identify a biomarker profile for ectopic
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pregnancy. To date, the vast majority of candidate biomarkers have been selected using
hypotheses derived from existing literature on ectopic pregnancy and related pathologies
[18,22]. Given recent advances in protein separation and mass spectrometry [23,24], it is
perhaps a little surprising that more headway has not been made in identifying novel
biological markers of ectopic pregnancy using global proteomic analysis. However, even the
most advanced mass spectrometers are limited in their ability to detect differences, no matter
how dramatic, in the expression of relatively rare proteins against the backdrop of a small
number of highly abundant proteins that is typical of biological samples. This is particularly
problematic in the case of human serum, where the 20 most abundant proteins make up
97-99% of the total protein complement [25]. Antibody based affinity columns designed to
specifically deplete these proteins from sera [26,27] have recently been deployed to help
overcome this obstacle [28]. This comprehensive one-dimensional gel electrophoresis/
multidimensional protein identification technology (1-DE MudPIT) study, which also
employed cutting-edge label-free quantitative mass spectrometry, identified a total of 70
proteins that appear to be differentially expressed in the serum of women with ectopic
pregnancies [28]. Subsequent validation studies have confirmed that at least one of these
proteins, ADAM-12, is effective at differentiating between ectopic and viable intrauterine
pregnancies [29]. Although antibody based depletion columns make moderately abundant
protein identification easier by removing the most abundant proteins, they do not modify the
dynamic range present in the remaining proteome. Righetti and Boschetti’s concept of using
a library of millions of different multimeric peptide baits to selectively enrich for low
abundance proteins [30,31] allowed Sennels et al to extend the number of serum proteins
identifiable by standard proteomics methods from 60 [32] to almost 4000 [33] and our initial
trials of this technology in concert with a 1-DE MudPIT approach suggest it has
considerable promise in the context of ectopic pregnancy biomarker discovery (data not
shown).
Lessons from functional studies
Embryo transport through the Fallopian tube is widely accepted to be regulated by a
combination of ciliary beat activity and smooth muscle contractions [5]. It is a dynamic
process that cannot, at this time, be observed directly in vivo and it is unlikely ever to be
open to functional analysis in this context in humans.
Ex vivo models for studying regulation of ciliary beat frequency (CBF) have been developed
in animals such as the guinea pig [34] and mouse [35,36], and using human Fallopian tube
biopsies [37,38]. In theory, CBF is relatively straightforward to measure using phase
contrast or differential contrast in concert with moderately high-speed (≥50 Hz) video [39]
or confocal laser scanning [40] microscopy (Fig. 1). This methodology is well suited to
agonist/antagonist studies but issues arise from the complex nature of the tissue biopsies,
with the potential presence of undefined endogenous agonists/antagonists. In addition,
imaging can be more complicated that expected due to the size, mobility and transparency of
the biopsies, often requiring sophisticated tissue preparation and presentation [35]. It is also
difficult to conduct these experiments in an unbiased manner as dead/immobile cilia are very
hard to see and less likely to be recorded. Nevertheless, this methodology has shown that
CBF is affected by a variety of factors: it is calcium dependent and requires adenosine
triphosphate; and beta-adrenergic stimuli, prostaglandins and angiotensin-II increase CBF,
whereas high-dose progesterone decreases it [41,42,43,44]. The methodology has also
demonstrated that ciliary activity appears to exhibit cyclical changes [35,45]. Although,
findings vary between speicies, with CBF in the fimbrial segment increasing in the luteal
phase of the menstrual cycle in humans [45] but decreasing during the estrus phase in mice
[35].
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Similarly, models of Fallopian tube contractility have been developed using simple
methodology involving the isolation of smooth muscle tissue strips or circles from Fallopian
tube biopsies under a stereomicroscope. The strips are mounted in chambers under tension
and contractions are recorded with a force-displacement transducer and registered on a
polygraph or digital data acquisition system (Fig. 2). This approach has demonstrated that
the stimulation of alpha adrenergic receptors promotes contraction of the oviductal muscles,
while stimulation of beta receptors inhibits contractions [46]. More recent studies have
shown that the sex steroid hormones and other factors produced by the oviduct itself, such as
nitric oxide [46,47,48], prostacyclin [49] and prostaglandins [49,50,51] may also modulate
smooth muscle contraction and play a lead role in embryo transport. This has been
complemented by exciting recent studies of murine oviduct smooth muscle contractility that
suggest that oviductal pacemaker activity may be damaged by nitric oxide produced in
NOS2-expressing macrophages in response to chlamydial infection [52,53].
Lessons from cell culture
There are numerous studies that describe human co-culture methods using human embryos
and endometrium for the study of endometrial biology [54]. Similar studies using Fallopian
tube, designed for further understanding of the aetiology of ectopic pregnancy are lacking
due to limited availability of cell lines and problems associated with the use of cells from
human Fallopian tubes for co-culture. Only two immortalized oviductal epithelial cell lines
have been established [55,56]. The isolation of the epithelial cells from the tubal tissues is
technically difficult; the number of cells prepared for co-culture is variable at each
opportunity; and tubal epithelial cells, grown in monolayer culture, lose morphological
features associated with the epithelium in situ, such as cilia. However, we are optimistic that
these problems may be overcome after the recent report of the development of a novel ex
vivo primary human Fallopian tube epithelium culture system that faithfully recapitulates
the in vivo epithelium, as shown by morphological, ultrastructural and immunophenotypic
analyses [57]. Co-culture studies using this model and trophoblast tissue or embryos
fertilized in-vitro could be useful in analyzing gene expression changes induced by
implantation in the Fallopian tube. The presence of ciliated cells in this system also raises
the prospect of a greatly simplified system with which to examine the mechanisms
regulating cilia function. Coupled with microarray and proteomic technologies, these studies
may prove useful in delineating similarities and differences between tubal and intrauterine
implantation.
Lessons from animal models
Several differences between primates (human and non-human) and animals suffering from
ectopic pregnancy exist primarily with regard to the site of ectopic implantation [6]. In
animals, the abdominal cavity is the most frequent extra-uterine implantation site and only
three cases of tubal pregnancy in primates have been reported to date [58,59]. Nevertheless,
important information pertaining to the aetiology of tEP has been derived from rodent
models [60]. The biological importance of the endocannabinoid receptor, CB1 in the tubal
transport process is illustrated by the presence of retained embryos in mice that lack either
CB1 or CB1/2, or mice that have been treated with synthetic CB1 antagonist [61]. Embryo
retention is also a characteristic of the deletion of Dicer1, ribonuclease III enzyme required
for micro-RNA processing. While the complete loss of Dicer1 in mice results in early
embryonic lethality [62], studies in female mice carrying a floxed allele of Dicer1 (under the
control of antimüllerian hormone receptor 2 promoter-driven Cre recombinase) have
revealed that these mice exhibit tubal hypotrophy with the formation of prominent tubal
cysts, leading to the disruption of tubal transport [63,64,65]. We believe that future studies
should be aimed at inducing tubal implantation in mice to generate useful animal models for
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ectopic pregnancy. For example, mouse models employing conditional knock-in of specific
genes important for implantation in the oviduct (ie. PROKs, COX-2, HOXA10 and LIF)
may result in mice in which embryos (fertilized in vivo or in vitro) implant within the
oviduct. Treatment of mice with agents aimed at directly disrupting tubal smooth muscle
contractility and/or ciliary beat activity, such as PROK, CB1 or NO antagonists may also
prove useful in developing an animal model of tubal implantation.
Conclusion
The absence of an animal model of tEP continues to confound attempts to delineate the
mechanisms that underlie the condition. The authors are optimistic that a genetically
modified mouse model of tEP, or at least implantation, is an achievable goal. In the
meantime, workers in the field will have to continue to make the most of clinical samples
and the in vitro models of Fallopian tube described in the current review.
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Key Points
• Data from human ex-vivo descriptive studies are associative and cannot be
ascribed to a cause or effect of ectopic pregnancy without appropriate follow-up
functional studies.
• The lack of a viable animal model of tubal ectopic pregnancy remains the key
obstacle to defining the aetiology of the condition.
• Global proteomic and genomic approaches are proving effective in identifying
potential biomarkers for ectopic pregnancy.
• A new primary human Fallopian tube epithelium culture system represents a
significant recent advance in the available laboratory models for studying
ectopic pregnancy
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Figure 1.
In vitro measurement of cilia beat frequency (CBF) using a confocal laser scanning
microscope. Fallopian tube (Lothian research ethics committee 04/S1103/20) was cut into
small (2×2 mm) pieces under aseptic conditions and incubated for 48 hrs at 37°C (5% CO2)
in RPIM supplemented with 10% FCS and antibiotics. Phase contrast images (512×10
pixels) were collected at 50Hz. A 3s time resolved single line scan through an active cilia is
shown (A). Images were subjected to edge enhancement (B) before measuring the
fluctuation in grey level over time (C) which corresponds to fluctuations in contrast cause by
the movement of the cilia (B: arrows). The CBF of individual cilia was calculated over a 10s
period using LabChart software (ADInstruments, Oxford, UK), individual CBF datum and
median CBF (3.09 Hz) are shown (D).
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Figure 2.
In vitro measurement of Fallopian tube smooth muscle contractility. Human tubal circular
smooth muscle rings were be dissected from the ampullo-isthmic junction of Fallopian tube
biopsies (Lothian research ethics committee 04/S1103/20) and mounted under 10 mN of
tension at 37°C in Kreb’s buffer + Glucose in a organ bath. The strips were attached to
isometric transducers and contractility recorded on a data acquisition system using LabChart
software (ADInstruments). This allowed fallopian tube smooth muscle contractility to be
monitored dynamically in the presence of agonists/antagonists. The effects of adding
increasing concentrations of Acetylecholine (Ach) on Fallopian tube smooth muscle
contractility are shown over time (A). LabChart software facilitates extraction and analysis
of a variety of parameters from the raw transducer data including mean force (B) and
contraction frequency (C).
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